Pharmaceutical investors counting on a strong flu season and sales of antivirals like Tamiflu, Amantadine, and Relenza may want to prepare for disappointment… almost all of them are below the norms as well as below expectations according to data from Nataxis Bleichroeder.
Amantadine prescriptions... Read More...
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to: